Starting Wegovy at 1 mg: what actually happens to your body

Picture this: you have your first Wegovy pen and you have heard that 1 mg is when it 'really kicks in'

It is a common piece of advice shared in weight-loss communities, and it is understandable why it circulates. The lower starter doses (0.25 mg for the first four weeks, then 0.5 mg) can feel almost imperceptible. You might wonder whether they are doing anything at all. So the temptation to begin at 1 mg is real, and it is worth being honest about that rather than just telling you not to do it.

Here is what is actually happening at those low doses. Semaglutide, the active ingredient in Wegovy, works by mimicking a gut hormone called GLP-1, which signals fullness, slows the rate at which your stomach empties, and influences appetite centres in the brain. Your GI tract needs time to adapt to that slowing effect. The 0.25 mg dose is not a therapeutic dose in the sense that it produces significant weight loss on its own, it is a settling-in period for your gut. Missing it means your digestive system meets the full pharmacological effect of 1 mg without that buffer. The result, for most people, is more nausea, more vomiting, and more diarrhoea in those opening weeks than they would have had otherwise. You can read more about the full dose pathway on the Wegovy doses overview page.

None of this means catastrophic harm, but it does mean a harder start for a benefit (faster weight loss) that the evidence does not support. The NHS semaglutide medicines page sets out the standard titration clearly, and it exists for good reason.

What side effects are more likely when you skip the lower steps

The side-effect profile of semaglutide is led by the gastrointestinal system at every dose. What changes when you jump to 1 mg without the lower rungs is intensity and timing rather than type. Nausea is the most commonly reported effect; constipation, loose stools, indigestion, burping and fatigue follow. At the starter doses these tend to be mild and settle within a week or two for most people. At 1 mg from day one, the same symptoms can be more severe and last longer.

There are also effects that warrant prompt medical attention regardless of which dose you are on: severe stomach pain that spreads to your back (which could indicate pancreatitis) should always be assessed urgently. The MHRA has highlighted acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines. Gallbladder symptoms, signs of dehydration from persistent vomiting, and any unusual allergic reaction also need same-day medical attention. You should report any suspected side effects through the Yellow Card scheme.

If you are already on treatment and wondering what to expect at the next step up, the 1.7 mg dose page covers that transition in detail. The principle is the same: each increase is gradual on purpose.

What the titration schedule is actually designed to do, and when 1 mg becomes your dose legitimately

There is a version of this question that is completely reasonable: your prescriber has decided that 1 mg is the right starting point for you. This can happen in specific clinical circumstances, for example if you have already been established on a similar GLP-1 medicine and your prescriber judges that your system has adapted. That is different from self-adjusting based on a forum post or a friend's experience.

In the standard licensed schedule, 1 mg arrives at week nine at the earliest, after four weeks at 0.25 mg and four weeks at 0.5 mg. From there, the maintenance pathway continues through 1.7 mg toward the 2.4 mg dose where the trial evidence (the STEP 1 study published in the New England Journal of Medicine) recorded an average body-weight reduction of around 15% over 68 weeks. That figure comes from participants taking 2.4 mg as the maintenance dose, not 1 mg. Starting higher earlier does not compress the timeline to that outcome; it just removes the safety margin built into the early weeks, and if you accidentally take more than you should you can find out what happens if you take 2 doses of Wegovy on our dedicated page. Information on what the 2.4 mg dose involves can be found on the 2.4 mg Wegovy page.

For context on the full treatment picture, including private access if you are not eligible for NHS Wegovy or cannot face the waiting list, the Wegovy cost page gives an honest breakdown of what private treatment involves and what is typically included in a transparent price. Suitability for treatment and the dose schedule are always determined by a prescriber; if you would like a clinical assessment, you can check your eligibility with our team. If you are already taking Wegovy and you miss an injection, our page on what happens if you miss a dose of Wegovy explains exactly what to do next.